1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in the vitamin D receptor content in the parathyroid glands of uremic rats

Kidney International

Volumn 50, Issue 1, 1996, Pages 34-39

  Denda, Masashi ^b   Finch, Jane ^b   Brown, Alex J ^b   Nishii, Yasuho ^b   Kubodera, Noboru ^b   Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D; VITAMIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0029839006     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.283     Document Type: Article

References (49)

1. SLATOPOLSKY E, CAGLAR S, PENELL JP, TAGART DB, CANTERBURY JM, REISS E, BRICKER NS: On the pathogenesis of hyperparalhyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 50:492-499, 1971
2. LOPEZ-HILKER S, DUSSO AS, RAPP NS, MARTIN KJ, SLATOPOLSKY E: Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 259:F432-F437, 1990
3. 3 on parathyroid hormone secretion, adenosine 3′, 5′-monophosphate release, and ultrastructure of parathyroid glands in organ cultures. Endocrinology 105:237-245, 1979
4. SLATOPOLSKY E, WEERTS C, THIELAN J, HORST R, HARTER H, MARTIN KJ: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
5. SILVER J, RUSSELL J, SHERWOOD LM: Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 82:4270-4273, 1985
6. 3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117:2114-2119, 1985
7. SILVER J, NAVEH-MANY T, MAYER H, SCHMELZER HJ, POPOVTZER MM: Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78:1296-1301, 1986
8. HAUSSLER MR: Vitamin D receptors: Nature and function. Ann Rev Nutr 6:527-562, 1986
9. HUNZIKER W, WALTERS MR, BISHOP JE, NORMAN AW: Effect of vitamin D status on equilibrium between occupied and unoccupied 1,25-dihydroxyvitamin D intestinal receptors in the chick. J Clin Invest 69:826-833, 1982
10. 3 and dexamethasone on rat osteoblast-like primary cell cultures: Receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology 118:250-259, 1986
11. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577, 1987
12. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 35:19-23, 1989
13. 3 in early renal failure. Miner Electrol Metab 11:182-185, 1985
14. 3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 117:2203-2210, 1985
15. 3: In vitro translation to characterize size and hormone-dependent regulation. Proc Natl Acad Sci USA 84:354-358, 1987
16. MCDONNELL DP, MANGELSDORF DJ, PIKE JW, HAUSSLER MR, O'MALLEY BW: Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:354-358, 1987
17. 3 receptor in rat osteosarcoma cells. J Biol Chem 262:4670-4675, 1987
18. 3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation. J Biol Chem 264:13701-13705, 1989
19. 3 receptor in vivo. Proc Natl Acad Sci USA 86:9770-9773, 1989
20. 3 receptor concentration in kidney in vivo. Biochemistry 87:4312-4314, 1990
21. 3 receptor in rats. Biochem Biophys Res Commun 137:742-747, 1986
22. PATEL SR, KE HQ, HSU CH: Regulation of calcitriol receptor and its mRNA in normal and renal failure rats. Kidney Int 45:1020-1027, 1994
23. DELMEZ JA, TIDIRA C, GROOMS P, DUSSO A, WINDUS DW, SLATOPOLSKY E: Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium. J Clin Invest 83:1349-1355, 1989
24. ANDRESS DL, KEITH MD, NORRIS C, COBURN JW, SLATOPOLSKY E: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
25. DUNLAY R, RODRIGUEZ M, FELSENFELD AJ, LLACH F: Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 36:1093-1098, 1989
26. 3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 57:23-28, 1991
27. GALLIENI M, BRANCACCIO D, PADOVESE P, ROLLA D, BEDANI P, TAROLO G: Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Kidney Int 42:1191-1198, 1992
28. CANELLA G, BONUCCI E, ROLLA D, BALLANTI P, MORIERO E, DEGRANDI R, AUGERI C, CLAUDIANI F, DI-MAIO G: Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 46:1124-1132, 1994
29. BROWN AJ, RITTER CR, FINCH JL, MORRISSEY J, MARTIN KJ, MURAYAMA E, NISHII Y, SLATOPOLSKY E: The non-calcemic analog of vitamin D, 22-oxacalcitriol (OCT) suppresses parathyroid hormone synthesis and secretion. J Clin Invest 84:728-732, 1989
30. FUKAGAWA M, KANAME S, IGARASHI T, OGATA E, KUROKAWA K: Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 39:874-881, 1991
31. 3-receptor complexes. Anal Biochem 92:314-323, 1979
32. BRADFORD M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
33. HOLLIS BW: Assay of circulating 1,25-dihydroxyvitamin D metabolites involving a novel single extraction and purification procedure. Clin Chem 32:2060-2063, 1986
34. REINHARDT TA, HORST RL, ORF W, HOLLIS BW: A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J Clin Endocrinol Metab 58:91-98, 1984
35. Dusso AS, NEGREA L, GUNAWARDHANA S, LOPES-HILKER S, FINCH J, MORI T, NISHII Y, SLATOPOLSKY E, BROWN AJ: On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128:1687-1692, 1991
36. DUSSO AS, NEGREA L, FINCH J, KAMIMURA S, LOPES-HILKER S, MORI T, NISHII Y, BROWN A, SLATOPOLSKY E: The effect of 22-oxacalcitriol on serum calcitriol. Endocrinology 130:3129-3134, 1992
37. 9k in uraemic rats. EurJ Clin Invest 21:521-526, 1991
38. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443, 1993
39. 3 in regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 132:2639-2644, 1993
40. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 136: 1419-1425, 1995
41. SRIUSSADAPORN S, WONG M, PIKE JK, FAVUS MJ: Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. J Bone Miner Res 10:271-280, 1995
42. REINHARDT TA, HORST RL: Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 127:942-948, 1990
43. 2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors. Endocrinology 126:1031-1035, 1990
44. DRÜEKE TB: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48:259-272, 1995
45. HSU CH, PATEL SR, VANHOLDER R: Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. Am J Physiol 264:F662-F669, 1993
46. PATEL SR, KE HQ, VANHOLDER R, KOENIG RJ, HSU CH: Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96:50-59, 1995
47. FAVUS MJ, MANGELSDOLF DJ, TEMBE V, COE BJ, HAUSSLER MR: Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat. J Clin Invest 82:218-224, 1988
48. 3 receptor turnover by dense amino acid labeling: Changes during receptor up-regulation by vitamin D metabolites. Endocrinology 120:1173-1178, 1987
49. 3 results from ligand-induced stabilization. J Biol Chem 267:20082-20086, 1992